Compare ACXP & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACXP | WKSP |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 7.0M |
| IPO Year | 2021 | 2015 |
| Metric | ACXP | WKSP |
|---|---|---|
| Price | $1.38 | $0.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $95.50 | $9.25 |
| AVG Volume (30 Days) | 77.2K | ★ 6.8M |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.89 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $16,101,738.00 |
| Revenue This Year | N/A | $131.96 |
| Revenue Next Year | N/A | $24.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 89.78 |
| 52 Week Low | $1.31 | $0.37 |
| 52 Week High | $8.34 | $3.90 |
| Indicator | ACXP | WKSP |
|---|---|---|
| Relative Strength Index (RSI) | 43.46 | 35.91 |
| Support Level | $1.33 | N/A |
| Resistance Level | $1.46 | $0.77 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 35.48 | 39.93 |
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Worksport Ltd designs, develops, and manufactures products for markets including automotive accessories, consumer electronics, and residential and commercial HVAC systems. The company leverages a growing intellectual property portfolio of patents, designs, and trademarks covering products such as tonneau covers, solar-integrated tonneau covers, portable power stations, hydrogen-based green energy systems, heat pumps, and EV charging solutions. Its segments include soft tonneau covers, consisting mainly of vinyl-wrapped tri-fold and quad-fold covers manufactured by third-party suppliers, and hard tonneau covers, which generate the majority of revenue in the United States and include aluminum tri-fold and quad-fold covers manufactured and assembled in the United States.